Abstract

Vitamin D inadequacy appears to be on the rise globally, and it has been linked to an increased risk of osteoporosis, as well as metabolic, cardiovascular, and autoimmune diseases. Vitamin D concentrations are partially determined by genetic factors. Specific single nucleotide polymorphisms (SNPs) in genes involved in vitamin D transport, metabolism, or binding have been found to be associated with its serum concentration, and these SNPs differ among ethnicities. Vitamin D has also been suggested to be a regulator of the gut microbiota and vitamin D deficiency as the possible cause of gut microbial dysbiosis and inflammation. This pilot study aims to fill the gap in our understanding of the prevalence, cause, and implications of vitamin D inadequacy in a pediatric population residing in Qatar. Blood and fecal samples were collected from healthy subjects aged 4–14 years. Blood was used to measure serum metabolite of vitamin D, 25-hydroxycholecalciferol 25(OH)D. To evaluate the composition of the gut microbiota, fecal samples were subjected to 16S rRNA gene sequencing. High levels of vitamin D deficiency/insufficiency were observed in our cohort with 97% of the subjects falling into the inadequate category (with serum 25(OH)D < 75 nmol/L). The CT genotype in rs12512631, an SNP in the GC gene, was associated with low serum levels of vitamin D (ANOVA, p = 0.0356) and was abundant in deficient compared to non-deficient subjects. Overall gut microbial community structure was significantly different between the deficient (D) and non-deficient (ND) groups (Bray Curtis dissimilarity p = 0.049), with deficient subjects also displaying reduced gut microbial diversity. Significant differences were observed among the two major gut phyla, Firmicutes (F) and Bacteroidetes (B), where deficient subjects displayed a higher B/F ratio (p = 0.0097) compared to ND. Vitamin D deficient children also demonstrated gut enterotypes dominated by the genus Prevotella as opposed to Bacteroides. Our findings suggest that pediatric vitamin D inadequacy significantly impacts the gut microbiota. We also highlight the importance of considering host genetics and baseline gut microbiome composition in interpreting the clinical outcomes related to vitamin D deficiency as well as designing better personalized strategies for therapeutic interventions.

Highlights

  • Vitamin D and its metabolites play a crucial role in early life, including bone growth [1]and development of the immune system [2]

  • Even though the cutoff of vitamin D deficiency and insufficiency varies between institutions, with some recommending levels above 75 nmol/L as sufficient or normal [4], the consensus is that ideal 25(OH)D levels should be greater than 50 nmol/L [5]

  • Subjects were excluded if they had chronic diseases, took antibiotics in the last month or were on vitamin D supplementation for the last six months before enrolment, failed to provide blood samples, and/or if their serum vitamin D status was unavailable

Read more

Summary

Introduction

Vitamin D and its metabolites play a crucial role in early life, including bone growth [1]and development of the immune system [2]. Even though the cutoff of vitamin D deficiency and insufficiency varies between institutions, with some recommending levels above 75 nmol/L as sufficient or normal [4], the consensus is that ideal 25(OH)D levels should be greater than 50 nmol/L [5]. This limit was based on data indicating levels less than 50 nmol/L are linked to a variety of disease outcomes [6]. In a cohort of 293 adolescent girls (11–18 years) living in the United Arab Emirates, the authors reported vitamin D deficiency (

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call